Healthcare

Healthcare

CloudMD (OTC: DOCRF) Signs Definitive Agreement to Acquire Majority Interest in West Mississauga Medical Clinic

August 14, 2020 admin Comments Off on CloudMD (OTC: DOCRF) Signs Definitive Agreement to Acquire Majority Interest in West Mississauga Medical Clinic

Secures footprint in Ontario with cash flow positive clinic, revenue of C$1.8 million in 2019 VANCOUVER, British Columbia, Aug. 13, 2020  — CloudMD Software & Services Inc. (TSXV: DOC, OTCQB: DOCRF, Frankfurt: 6PH) (the “Company” […]

Healthcare

CloudMD (OTC: DOCRF) Continues U.S. Expansion with Acquisition of U.S. Based Chronic Care Medical Clinic

August 6, 2020 admin Comments Off on CloudMD (OTC: DOCRF) Continues U.S. Expansion with Acquisition of U.S. Based Chronic Care Medical Clinic

CloudMD will implement its telehealth technology across clinic network Digital healthcare and telemedicine are the great equalizer for healthcare delivery; demand is surging and part of the new normal.  The U.S. recently has made swift […]

Healthcare

Teladoc (NYSE: TDOC) CEO Jason Gorevic: “Pandemic Accelerated Widespread Adoption of Virtual Care”.

August 6, 2020 admin Comments Off on Teladoc (NYSE: TDOC) CEO Jason Gorevic: “Pandemic Accelerated Widespread Adoption of Virtual Care”.

      Teladoc Health, Inc. (NYSE: TDOC) Q2 2020 Earnings Call Highlights Jason Gorevic, CEO “…We reported the results of our second quarter, 2020, which was characterized by outperformance across all key financial and operational metrics driven […]

Healthcare

CloudMD (OTC: DOCRF) to Acquire Snapclarity Inc., an Enterprise Mental Health Platform, Expanding Telehealth Offering to Include Mental Wellness

July 18, 2020 admin Comments Off on CloudMD (OTC: DOCRF) to Acquire Snapclarity Inc., an Enterprise Mental Health Platform, Expanding Telehealth Offering to Include Mental Wellness

A silent mental health crisis existed before the COVID-19 pandemic and has now been brought to the forefront as a crisis on its own. COVID 19 has created a global focus on mental and physical […]

Healthcare

Valeo Pharma Receives Approval from Health Canada for the Transfer of Commercial Rights to Ametop™

July 14, 2020 admin Comments Off on Valeo Pharma Receives Approval from Health Canada for the Transfer of Commercial Rights to Ametop™

AmetopTM commercialization to begin in July 2020 First of four Valeo products scheduled for launch this summer MONTREAL , July 13, 2020  – Valeo Pharma Inc. (VPH.CN) (“Valeo” or the “Company“), a Canadian specialty pharmaceutical company,  announced today […]

Healthcare

CytoDyn to Prepare a Phase 3 Protocol to Submit to the FDA for a Three-Arm Comparative and Combination Trial of Leronlimab and Remdesivir

May 18, 2020 admin Comments Off on CytoDyn to Prepare a Phase 3 Protocol to Submit to the FDA for a Three-Arm Comparative and Combination Trial of Leronlimab and Remdesivir

VANCOUVER, Washington, May 18, 2020 — Three arms of this trial will be leronlimab, remdesivir, and leronlimab + remdesivir CytoDyn Inc. (OTC.QB: CYDY), (“CytoDyn” or the “Company”), a late-stage biotechnology company developing leronlimab (PRO 140), […]

Healthcare

CytoDyn (OTC: CYDY) to Offer No-Cost Exploratory Laboratory Testing for Childhood Inflammatory Disease Associated with COVID-19

May 15, 2020 admin Comments Off on CytoDyn (OTC: CYDY) to Offer No-Cost Exploratory Laboratory Testing for Childhood Inflammatory Disease Associated with COVID-19

VANCOUVER, Washington, May 15, 2020– CytoDyn Inc. (OTC.QB: CYDY), (“CytoDyn” or the “Company”), a late-stage biotechnology company developing leronlimab (PRO 140), a CCR5 antagonist with the potential for multiple therapeutic indications, today announced it is […]